BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 16151476)

  • 1. Targeting of autonomous parvoviruses to colon cancer by insertion of Tcf sites in the P4 promoter.
    Malerba M; Nikolova D; Cornelis J; Iggo R
    Cancer Gene Ther; 2006 Mar; 13(3):273-80. PubMed ID: 16151476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Replicating parvoviruses that target colon cancer cells.
    Malerba M; Daeffler L; Rommelaere J; Iggo RD
    J Virol; 2003 Jun; 77(12):6683-91. PubMed ID: 12767988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenoviruses with Tcf binding sites in multiple early promoters show enhanced selectivity for tumour cells with constitutive activation of the wnt signalling pathway.
    Fuerer C; Iggo R
    Gene Ther; 2002 Feb; 9(4):270-81. PubMed ID: 11896466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Replicating adenoviruses that target tumors with constitutive activation of the wnt signaling pathway.
    Brunori M; Malerba M; Kashiwazaki H; Iggo R
    J Virol; 2001 Mar; 75(6):2857-65. PubMed ID: 11222711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fusion of the BCL9 HD2 domain to E1A increases the cytopathic effect of an oncolytic adenovirus that targets colon cancer cells.
    Fuerer C; Homicsko K; Lukashev AN; Pittet AL; Iggo RD
    BMC Cancer; 2006 Oct; 6():236. PubMed ID: 17020613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of SP5 as a downstream gene of the beta-catenin/Tcf pathway and its enhanced expression in human colon cancer.
    Takahashi M; Nakamura Y; Obama K; Furukawa Y
    Int J Oncol; 2005 Dec; 27(6):1483-7. PubMed ID: 16273202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurotensin receptor 1 gene activation by the Tcf/beta-catenin pathway is an early event in human colonic adenomas.
    Souazé F; Viardot-Foucault V; Roullet N; Toy-Miou-Leong M; Gompel A; Bruyneel E; Comperat E; Faux MC; Mareel M; Rostène W; Fléjou JF; Gespach C; Forgez P
    Carcinogenesis; 2006 Apr; 27(4):708-16. PubMed ID: 16299383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy approach in prostate cancer cells using an active Wnt signal.
    Giladi N; Dvory-Sobol H; Sagiv E; Kazanov D; Liberman E; Arber N
    Biomed Pharmacother; 2007 Oct; 61(9):527-30. PubMed ID: 17904788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of human neurotropic JCV in colon cancer cells.
    Enam S; Gan DD; White MK; Del Valle L; Khalili K
    Anticancer Res; 2006; 26(2A):833-41. PubMed ID: 16619477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective treatment of tumors with strong beta-catenin/T-cell factor activity by transcriptionally targeted oncolytic herpes simplex virus vector.
    Kuroda T; Rabkin SD; Martuza RL
    Cancer Res; 2006 Oct; 66(20):10127-35. PubMed ID: 17047077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mastermind-like 1 Is a specific coactivator of beta-catenin transcription activation and is essential for colon carcinoma cell survival.
    Alves-Guerra MC; Ronchini C; Capobianco AJ
    Cancer Res; 2007 Sep; 67(18):8690-8. PubMed ID: 17875709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of gastric cancer cell growth by targeting the beta-catenin/T-cell factor pathway.
    Dvory-Sobol H; Sagiv E; Liberman E; Kazanov D; Arber N
    Cancer; 2007 Jan; 109(2):188-97. PubMed ID: 17149756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosomal instability by beta-catenin/TCF transcription in APC or beta-catenin mutant cells.
    Aoki K; Aoki M; Sugai M; Harada N; Miyoshi H; Tsukamoto T; Mizoshita T; Tatematsu M; Seno H; Chiba T; Oshima M; Hsieh CL; Taketo MM
    Oncogene; 2007 May; 26(24):3511-20. PubMed ID: 17160019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the glutathione peroxidase 2 (GPx2) promoter by beta-catenin.
    Kipp A; Banning A; Brigelius-Flohé R
    Biol Chem; 2007 Oct; 388(10):1027-33. PubMed ID: 17937616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FGF signaling inhibitor, SPRY4, is evolutionarily conserved target of WNT signaling pathway in progenitor cells.
    Katoh Y; Katoh M
    Int J Mol Med; 2006 Mar; 17(3):529-32. PubMed ID: 16465403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorectal cancer and genetic alterations in the Wnt pathway.
    Segditsas S; Tomlinson I
    Oncogene; 2006 Dec; 25(57):7531-7. PubMed ID: 17143297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redundant expression of canonical Wnt ligands in human breast cancer cell lines.
    Benhaj K; Akcali KC; Ozturk M
    Oncol Rep; 2006 Mar; 15(3):701-7. PubMed ID: 16465433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
    Shan BE; Wang MX; Li RQ
    Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative integromics on Ephrin family.
    Katoh Y; Katoh M
    Oncol Rep; 2006 May; 15(5):1391-5. PubMed ID: 16596216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wnt induction of chondrocyte hypertrophy through the Runx2 transcription factor.
    Dong YF; Soung do Y; Schwarz EM; O'Keefe RJ; Drissi H
    J Cell Physiol; 2006 Jul; 208(1):77-86. PubMed ID: 16575901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.